Modulation of Atherogenesis by Dietary Gamma-Linolenic Acid

Author(s):  
Yang-Yi Fan ◽  
Kenneth S. Ramos ◽  
Robert S. Chapkin
2011 ◽  
Vol 60 (12) ◽  
pp. 597-607 ◽  
Author(s):  
Asuka Kawamura ◽  
Katsuhiko Ooyama ◽  
Keiichi Kojima ◽  
Hisanori Kachi ◽  
Tatsuichirou Abe ◽  
...  

2006 ◽  
Vol 34 (4) ◽  
pp. 1033-1038 ◽  
Author(s):  
Pierre Singer ◽  
Myriam Theilla ◽  
Haran Fisher ◽  
Lilly Gibstein ◽  
Elad Grozovski ◽  
...  

2006 ◽  
Vol 20 (1) ◽  
pp. 9-12 ◽  
Author(s):  
J. L. Guil-Guerrero ◽  
J. C. López-Martínez ◽  
R. Navarro-Juárez ◽  
F. Gómez-Mercado

1990 ◽  
Vol 28 (18) ◽  
pp. 69-70

Epogam capsules (Scotia) contain oil from the seed of the evening primrose which is rich in the essential fatty acid linoleic acid and its metabolite gamolenic (gamma-linolenic) acid. Epogam is licensed for use to relieve symptoms in atopic eczema, and is claimed to act at a fundamental metabolic level in this disease. Conventional treatment of eczema is often unsatisfactory, and any claim of an advance must be taken seriously. How well founded are the claims made for Epogam?


Sign in / Sign up

Export Citation Format

Share Document